MKI67 and neoplasm: We repeated this experiment in Tlr2−/− mice and saw no significant difference in tumor burden, Ki67 or SASP expression (Figure S4B), confirming that Pam2CSK4 acts via Tlr2 to mediate its anti-tumor response.